Showing results (641-650 of 903) with videos related to
Sort By:
Pageof 91
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2015
Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasmsAndrej Potthoff, Dina Attia, Sven Pischke, et al.Plos One|November 13, 2014
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosisBenjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2013
Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinomaMartha M Kirstein, Aristeidis E Boukouris, Deepika Pothiraju, et al.Frontiers in Immunology|August 28, 2024
Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic responseKlaus Schughart, Amber M Smith, Ephraim L Tsalik, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2002
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosisStefanie U Wiemann, Ande Satyanarayana, Martina Tsahuridu, et al.Transplantation|March 9, 2002
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumorsJens Rosenau, Matthias J Bahr, Reinhard von Wasielewski, et al.Gastroenterology|August 5, 2008
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathwayLydia A Haile, Reinhard von Wasielewski, Jaba Gamrekelashvili, et al.European Journal of Immunology|December 17, 2013
Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancersBenjamin Brinkhoff, Dmitrij Ostroumov, Jessica Heemcke, et al.Journal of Immunological Methods|November 26, 2002
Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexesTim F Greten, Firouzeh Korangy, Gunnar Neumann, et al.Journal of Gastroenterology and Hepatology|February 11, 2017
Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral centerMartha M Kirstein, Nora Schweitzer, Theresa Winter, et al.Pageof 91